Oxycodone Versus Sufentanil in Patient-controlled Intravenous Analgesia After Laparoscopic Hysterectomy

ConditionLaparoscopic Hysterectomy

Trial statusRecruiting

Trial phasePhase 4

Trial typeInterventional

Biological sexFemale

Age18-65

SponsorAffiliated Hospital of Nantong University

About this trial

This study is designed to evaluate the efficacy and safety of hydrocodone in patient-controlled intravenous analgesia (PCIA) during gynecological laparoscopy, thus to explore suitable PCIA scheme to optimize postoperative pain management for patients undergoing gynecological laparoscopic surgeries.

Eligibility criteria

Qualifiers

selective laparoscopic hysterectomy

general anesthesia

ASA classification I - III

aged 18 - 65 years

Disqualifiers

allergy to oxycodone or any other drugs will be used in the study

preoperative opioids medication

opioids abuse

hepatic or renal dysfunction

Trial design

Treatments tested in this trial

patient controlled intravenous analgesia(PCIA)
patient controlled intravenous analgesia(PCIA)

Treatment groups

64 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Affiliated Hospital of Nantong University

Lead sponsor

Source ClinicalTrials.gov